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Cyclic di-AMP (c-di-AMP) is a recently discovered secondmessenger in bacteria. Most of work on c-di-AMP signaling has been
done in Gram-positive bacteria, firmicutes, and actinobacteria, where c-di-AMP signaling pathways affect potassium transport,
cell wall structure, and antibiotic resistance. Little is known about c-di-AMP signaling in other bacteria. Borrelia burgdorferi, the
causative agent of Lyme disease, is a spirochete that has a Gram-negative dual membrane. In this study, we demonstrated that B.
burgdorferi BB0619, a DHH-DHHA1 domain protein (herein designated DhhP), functions as c-di-AMP phosphodiesterase. Re-
combinant DhhP hydrolyzed c-di-AMP to pApA in aMn2- or Mg2-dependent manner. In contrast to c-di-AMP phosphodies-
terases reported thus far, DhhP appears to be essential for B. burgdorferi growth both in vitro and in the mammalian host. Inac-
tivation of the chromosomal dhhP gene could be achieved only in the presence of a plasmid-encoded inducible dhhP gene. The
conditional dhhPmutant had a dramatic increase in intracellular c-di-AMP level in comparison to the isogenic wild-type strain.
Unlike what has been observed in Gram-positive bacteria, elevated cellular c-di-AMP in B. burgdorferi did not result in an in-
creased resistance to -lactamase antibiotics, suggesting that c-di-AMP’s functions in spirochetes differ from those in Gram-
positive bacteria. In addition, the dhhPmutant was defective in induction of theS factor, RpoS, and the RpoS-dependent outer
membrane virulence factor OspC, which uncovers an important role of c-di-AMP in B. burgdorferi virulence.
Nucleotide signaling molecules play a key role in regulatingcellular activities throughout all kingdoms of life. Cyclic di-
AMP (c-di-AMP) is a secondmessenger recently identified inBac-
teria (for reviews, see references 1, 2, 3, 4, and 5). It was initially
discovered in a structural study of the DisA protein (DNA integ-
rity scanning protein) of Bacillus subtilis and Thermotoga mari-
tima, where it was found bound to DisA (6). Cyclic di-AMP is
synthesized from two molecules of ATP by diadenylate cyclase
(DAC), which contains a conserved DisA_N domain (diadenylate
cyclase, DUF147), and is hydrolyzed to pApA, or AMP, by phos-
phodiesterases (PDEs) containing the DHH (conserved Asp-His-
His motif) and DHHA (DHH-associated domain) protein do-
mains (5, 7). Genomic analyses revealed that proteins containing
DisA_N and DHH-DHHA domains are encoded in the genomes
of many Bacteria as well as some Archaea, suggesting that c-di-
AMP signaling systems are widespread (1, 5).
Although the function of c-di-AMP remains poorly under-
stood, it appears to be an essential molecule, since attempts to
inactivate the DAC genes have failed in all bacterial species where
they have beenmade (8–14). B. subtilis contains three DAC genes,
but at least one of the three is needed for cell growth (15). On the
other hand, the c-di-AMP-specific PDE genes proved to be dis-
pensable, and the corresponding mutants have been obtained in
several Gram-positive bacteria (Firmicutes), including B. subtilis,
Staphylococcus aureus, Streptococcus pneumoniae, Listeria monocy-
togenes, and Lactococcus lactis (7, 8, 16–18). Most of these PDEs
belong to the GdpP protein family (GGDEF domain protein-con-
taining Phosphodiesterase) (Fig. 1), as they contain N-terminal
transmembrane helices linked to the highly degenerate GGDEF
domain and PAS domain (Per-Arnt-Sim domain, known to be
involved in binding to small-moleculemetabolites) (19), followed
by the DHH-DHHA1 domain module (20).
Studies on the c-di-AMP PDE-defective mutants indicate that
increased intracellular c-di-AMP levels correlate with increased
cell resistance to environmental stresses, such as acid stress, heat
stress, UV irradiation, and antibiotics (8, 16, 17, 21, 22). Increased
stress resistance may be due to an increased peptidoglycan cross-
linking (8, 15). The gdpP mutant of S. aureus also rescued the
severe growth defects of mutants lacking lipoteichoic acids (21).
In addition, elevated intracellular levels of c-di-AMP also resulted
in impaired cell size or cell division in B. subtilis (5), S. aureus, and
S. pneumoniae (7, 15, 21). Deletion of the c-di-AMP-dependent
transcriptional repressor DarR in Mycobacterium smegmatis also
led to increased cell length (23). Recently identified RCK_C do-
main (regulator of conductance of K) was regarded as a c-di-
AMP binding domain and a c-di-AMP binding protein (CabP) in
S. pneumoniae interacting with a K transporter has linked c-di-
AMP with K transport (24, 25).
In termof pathogenesis, c-di-AMPhas been shown to function
as PAMP (pathogen-associated molecular patterns), secreted
through the multidrug resistance transporter (MTR) system of L.
monocytogenes to the host cytosol, where it triggers STING (stim-
ulator of interferon genes)-mediated activation of the interferon
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(IFN) response. Inactivation of c-di-AMP PDE genes resulted in
reduced infection in several pathogens, including L. monocyto-
genes, S. pyogenes, and S. pneumoniae (7, 8, 22, 26).
Virtually all the studies on c-di-AMP done thus far were con-
ducted inGram-positive bacteria, with the exception of one recent
study showing that the Gram-negative bacterium Chlamydia tra-
chomatis produces c-di-AMP (27). It was shown that c-di-AMP
produced by C. trachomatis DAC is largely responsible for Chla-
mydia-induced STING-dependent type I IFN response in infected
mammalian cells. However, the cellular functions of c-di-AMP in
Gram-negative bacteria have not yet been examined.
Borrelia burgdorferi is a spirochetal pathogen and the causative
agent of Lyme disease (28). Spirochetes are a phylogenetically dis-
tinct branch of Bacteria. Similar to other Gram-negative bacteria,
spirochetes have a dual membrane structure with a thin layer of
peptidoglycan located in the periplasmic space. The natural hosts
of B. burgdorferi are ticks and mammals. B. burgdorferi undergoes
massive transcriptome and proteome changes upon pathogenmi-
gration between these two drastically different hosts (29–31).
Amazingly, B. burgdorferi accomplishes these dramatic processes
with its streamlined genome and limited regulatory repertoire
(32). For example, in contrast to many bacteria that have numer-
ous c-di-GMP signaling systems (33–36), B. burgdorferi has only
one c-di-GMP synthase (BB0419, diguanylate cyclase), and it
plays an essential role in spirochetal survival in ticks as well as
modulating B. burgdorferi motility and mammalian infection
(37–43).
In this study, we began investigating the c-di-AMP signaling
pathways of B. burgdorferi. We identified a gene for the DHH-
DHHA1 domain protein BB0619, herein designated DhhP, in the
B. burgdorferi genome and demonstrated that the protein func-
tions as a c-di-AMP phosphodiesterase. Surprisingly, we found
that, unlike what has been reported for Gram-positive bacteria,
DhhP is essential for B. burgdorferi growth, and conditional inac-
tivation of dhhP did not result in an increased resistance to -lac-
tam antibiotics, suggesting that c-di-AMP functions may differ in
different phyla of bacteria. In addition, the conditional dhhPmu-
tant is also defective in production of the major virulence factor
OspC and in mammalian infection.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The low-passage, virulent B.
burgdorferi strain 5A4NP1 (Table 1) (a gift from H. Kawabata and S.
Norris, University of Texas Health Science Center at Houston) was de-
rived from wild-type strain B31 by inserting a kanamycin resistance
marker in the restriction modification gene bbe02 on plasmid lp25 (44).
Borrelia organisms were cultivated in Barbour-Stoenner-Kelly (BSK-II)
medium supplemented with 6% normal rabbit serum (Pel Freez Biologi-
cals, Rogers, AR) (45) at 37°C with 5% CO2. Relevant antibiotics were
added to the cultures with the following final concentrations: 250 g/ml
for kanamycin, 50 g/ml for streptomycin, and 50 g/ml for gentamicin.
The constructed suicide vector (pMP001) was maintained in Escherichia
coli strain DH5. The antibiotics concentration used in E. coli were as
follows: ampicillin, 100g/ml; chloramphenicol, 20g/ml; and gentami-
cin, 10 g/ml.
Protein expression and purification. To obtain the recombination
protein DhhP-6His, the full-length dhhP (bb0619) gene was PCR am-
plified from B. burgdorferi strain B31 genomic DNA using the primer pair
pLATE31-dhhP F/pLATE31-dhhP R (Table 2) and cloned into pLATE31
(Thermo Scientific aLICator LIC cloning and expression system) to gen-
erate pMP032. The DhhP-6His fusion protein was expressed in
BL21(DE3) and purified as previously described (46). Briefly, exponen-
tially grown cells (A600, 0.6) were induced for 5 h with 0.3 mM (final
concentration) isopropyl--D-thiogalactopyranoside (IPTG) at 25°C.
Cells were pelleted and resuspended in a buffer containing 300mMNaCl,
50 mM NaH2PO4 (pH 7.4), 5% glycerol, and protease inhibitors (phen-
ylmethylsulfonyl fluoride and P8465; Sigma, St. Louis, MO) at the con-
centrations specified by themanufacturer. Cells were subjected to disrup-
tion in a French pressure minicell (Spectronic Instruments), followed by
brief sonication (Sonifier 250; Branson). Crude cell extracts were centri-
fuged at 35,000 g for 25min, and the supernatant was loaded ontoCo2
resin (Pierce) for affinity purification. After washing, proteins were eluted
with 280 mM imidazole and desalted via Zeba Spin desalting columns
(7-kDa cutoff; Pierce) that had been pre-equilibrated with buffer (300
mm NaCl, 0.5 mm EDTA, 10% glycerol, 50 mm NaH2PO4 [pH 7.4]).
Protein purity was assessed by SDS-PAGE (sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis). Protein concentration was measured us-
ing a Bradford protein assay kit (Bio-Rad).
Enzymatic assay.The phosphodiesterase assay conditions were essen-
tially as described previously (17), with minor modifications. A reaction
mixture (total volume, 0.6 ml) contained 0.5 MDhhP and 50 M c-di-
AMP (Axxora) in the buffer 20 mM Tris (pH 8.0), 80 mM KCl, 10 mM
metal cation (2.5 mM for Mn2). The reaction was carried out at 37°C.
Aliquots were withdrawn and immediately boiled for 5 min, followed by
centrifugation at 15,000  g for 10 min. The supernatant was filtered
through a 0.22-m filter and analyzed by reversed-phase high-pressure
liquid chromatography (HPLC) (Summit HPLC system; Dionex, Sunny-
vale, CA) on a 15-cm by 4.6-mm Supelcosil LC-18-T column (Sigma)
(47).
Measurements of intracellular c-di-AMP. B. burgdorferi organisms
were grown in BSK-II medium to stationary phase, harvested in 4°C at
12,000 g for 10 min, and immediately frozen in liquid nitrogen before
being stored at 80°C. Nucleotides were extracted from frozen B. burg-
dorferi biomass by a mixture of 40%methanol–40% acetonitrile in 0.1 N
formic acid as described earlier (48). The nucleotides were separated by
HPLC and quantified by using liquid chromatography-tandem mass
spectrometry (LC-MS/MS) on a Quattro Premier XE mass spectrometer
(Waters Corporation) coupled with an Acquity Ultra Performance LC
system (Waters Corporation) at the Michigan State Mass Spectrometry
Core Facility. Cyclic di-AMP standards of known concentrations were
FIG 1 Diagram of the domain structure of the GdpP-family c-di-AMP PDEs
and B. burgdorferi DhhP. TM, transmembrane domain.
TABLE 1 B. burgdorferi strains used in this study
Strain Description Reference or source
5A4NP1 B. burgdorferi B31 with bbe02 disrupted with a kanamycin-resistant marker 44
5A4NP1/pJJ01 5A4NP1 harboring an extra copy of the IPTG-inducible gene dhhP This study
5A4NP1 dhhP/pJJ01 5A4NP1/pJJ01 with the endogenous gene dhhP disrupted by a gentamicin-resistant marker This study
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used for quantification. For intracellular c-di-AMP concentration mea-
surements, the following simplifying assumptions were made: a Borrelia
cell has a cylindrical shape 0.25m in diameter and 25m in length (49);
therefore, an average cell volume was calculated to be 1.227 1015 liter.
Construction of the conditionaldhhPmutant.Wefirst constructed a
wild-type strain carrying a plasmid-borne copy of dhhP under the control
of an IPTG-inducible promoter. First, the full-length dhhP gene was PCR
amplified from 5A4NP1 genomic DNA using the primer pair pJJ01-F/
pJJ01-R and cloned into an IPTG-inducible shuttle vector, pJJ275, a de-
rivative of pJSB275 (50) with the addition of a hemagglutinin (HA)
epitope tag (amino acid sequence, YPYDVPDYA) (51) at the C terminus
of the inserted gene. The resulting plasmid was designed pJJ01. pJJ01 was
then transformed into 5A4NP1 using the method described previously
(52, 53). The final strain, 5A4NP1/pJJ01, was confirmed by immunoblot-
ting with anti-HA antibody.
To inactivate the endogenous dhhP gene in 5A4NP1/pJJ01, a suicide
vector, pMP001, was constructed for homologous recombination as fol-
lowing: the regions of DNA corresponding to 1.4 kb upstream and 1.4 kb
downstream of dhhP were PCR amplified from 5A4NP1 genomic DNA
with the primer pairs bb0619-UF/bb0619-UR and bb0619-DF/
bb0619-DR (Table 2), respectively. The resulting PCR fragments were
cloned into the vector pSC-A-amp/kan (Agilent Technologies) by T-A
cloning and confirmed by restriction enzyme digestion and sequencing.
The aaC1 gentamicin-resistant marker driven by the B. burgdorferi flaB
promoter (54) was digested out from pMH85R at the AatII sites (38) and
was ligated between the upstream and downstream fragments of dhhP to
generate the suicide vector pMP001. pMP001 was confirmed by both
restriction enzymedigestion and sequencing andused for transformation.
Cell lysates of positive Borrelia transformants were analyzed by PCR to
confirm corrected marker insertion and inactivation of the chromosomal
copy of dhhP. Plasmid profiles of the confirmed 5A4NP1 dhhP/pJJ01
clones were determined bymultiple PCR analyses with 19 pairs of primers
specific for each of the endogenous plasmids as reported by Bunikis et al.
(55). One of the 5A4NP1 dhhP/pJJ01 clones that had plasmid profiles
identical to those of the parental strain (5A4NP1) was chosen for further
study.
Growth curve and cell morphology. B. burgdorferi strains, including
the conditional dhhP mutant, were first grown in the presence of 1 mM
IPTG. To avoid carryover of IPTG from the seed cultures used for inocu-
lation, harvested cells were washed twice with PBS to remove residual
IPTG. Then the IPTG-free cells were recultured in the fresh BSK-II me-
dium with (5A4NP1 dhhP/pJJ01IPTG) or without (5A4NP1 dhhP/
pJJ01IPTG) IPTG. Either a low (3  104 cells/ml) or high (3  105
cells/ml) dose of cells was used for inoculation (indicated in the figure
legends). Cell numbers were numerated in every 12 or 24 h under dark-
field microscopy. Cell morphology was visualized by dark-field micros-
copy, and the images were taken at amagnification of500. Ten different
fields were selected for measuring the cell length of each strain, and 10
spirochetes in each field were randomly selected for measurement.
In vitro antimicrobial susceptibility test. MICs of B. burgdorferi
strains were determined by a standard broth microdilutionmethod using
96-well tissue culture plates as previously described (56). Wild-type
5A4NP1, 5A4NP1 dhhP/pJJ01IPTG, and 5A4NP1 dhhP/pJJ01IPTG
were incubated at 106 cells perml in BSK-IImedium containing a series of
2-fold dilutions of ampicillin, aztreonam, cefuroxime, cefixime, vanco-
mycin, and oxacillin (a total volume of 220l per well). The culture plates
were sealed with Parafilm and were incubated for 72 h at 37°C. The lowest
concentration of antibiotics that showed inhibition (lack of a color change
of the BSK II medium) was interpreted as the MIC.
Quantitative RT-PCR (qRT-PCR) and qPCR. RNA samples were ex-
tracted from B. burgdorferi cultures using the RNeasy minikit (Qiagen,
Valencia, CA) according to themanufacturer’s protocols. Three indepen-
dent culture samples were used for each strain. Digestion of contaminat-
ing genomic DNA in RNA samples was performed using RNase-free
DNase I (Promega), and removal of DNA was confirmed by PCR ampli-
fication for the B. burgdorferi flaB gene. cDNA was synthesized using the
SuperScript III reverse transcriptase with random primers (Invitrogen,
Carlsbad, CA). To quantify the transcript levels of genes of interest, an
absolute quantitation method was used by creating a standard curve in
qPCR assay by following the manufacturer’s protocol (Stratagene, La
Jolla, CA). Briefly, the PCR product of recA gene served as a standard
template. A series of 10-fold dilutions (102 to 108 copies/ml) of the stan-
dard template was prepared, and qPCRwas performed to generate a stan-
dard curve by plotting the initial template quantity against the cycle
threshold (CT) values for the standards. The quantity of the targeted genes
in cDNA samples was calculated using their CT values and the standard
TABLE 2 Primers used in the study
Primer Sequence (5=¡ 3=) Purpose
pLATE31-dhhP F AGAAGGAGATATAACTATGAGAGATGTTATTAATTTTATT Purify DhhP
pLATE31-dhhP R GTGGTGGTGATGGTGATGGCCTAAATAAATATTATCCTTAATG Purify DhhP
bb0619-UF TTGCGAATTCTCCCAAGCTTAAAAGCTCTTCTTGT Construct pMP001
bb0619-UR TTCGGACGTCTCAAAATCAGGATCTTTGTGCCC Construct pMP001
bb0619-DF TCGAGACGTCAGATTTTGGAGGCGGTGGGCA Construct pMP001
bb0619-DR TAGCGGATCCAAGGGGGATTGGCGCAGCAC Construct pMP001
pJJ01-F CCATGGAGCTCTTTTGCGGAAGGTTTGCGAA Construct pJJ01
pJJ01-R GGCCCTCGAGTAAATAAATATTATCCTTAATGTATG Construct pJJ01
dhhP ID-P1 ATGTTACGCAGCAGCAACGATGTTACGC Verify the dhhP mutant
dhhP ID-P2 CTCCAGGATCCGTCGACTTTAGGTGGCGGTACTTGGGTCG Verify the dhhP mutant
dhhP ID-P3 ATTTCGTGCTTTTTCTGCCAT Verify the dhhP mutant
dhhP ID-P4 TGGAACAACACCCTTGGCAT Verify the dhhP mutant
dhhP ID-P5 AGTCGGCCATTACGTGGAAA Verify the dhhP mutant
dhhP ID-P6 ATCAAGAAGGGGGATTGGCG Verify the dhhP mutant
dhhP ID-P7 TTCGGAGACGTAGCCACCTA Verify the dhhP mutant
dhhP ID-P8 CAACAACCGCTTCTTGGTCG Verify the dhhP mutant
dhhP ID-P9 AGAAGGAGATATAACTATGAGAGATGTTATTAATTTTATT Verify the dhhP mutant
dhhP ID-P10 GTGGTGGTGATGGTGATGGCCTAAATAAATATTATCCTTAATG Verify the dhhP mutant
qdhhP-F GGGCTATATTGATCCTTTTGCACC qRT-PCR
qdhhP-R TGAAACCAGTCTTGCAACCA qRT-PCR
qbosR-F ACTGTTGCTTTTGATAGGCTTGG qRT-PCR
qbosR-R CGCATTGGAAAAAGTCGGCA qRT-PCR
Ye et al.
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curve. Samples were performed in triplicate using the ABI 7000 sequence
detection systemand greenPCRmastermix (ABI, Pleasanton,CA). Levels
of the target gene transcript were reported per 100 copies of recA tran-
scripts.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and immunoblotting. Spirochetes were harvested by centrifuga-
tion at 8,000 g for 10 min and washed three times with PBS (pH 7.4) at
4°C. Pellets were suspended in SDS buffer containing 50 mM Tris-HCl
(pH 8.0), 0.3% sodium dodecyl sulfate (SDS), and 10 mM dithiothreitol
(DTT). Cell lysates (5  107 cells per lane) were separated by 12% SDS-
polyacrylamide gel electrophoresis (PAGE) and transferred to nitrocellu-
lose membranes (GE-Healthcare, Milwaukee, WI). Membranes were
blotted with monoclonal antibodies against FlaB, OspC, RpoS, and BosR
(57–59) with 1:500, 1:1,000, 1:50, and 1:500 dilutions, respectively, and
thenwith goat anti-mouse IgGhorseradish peroxidase (HRP)-conjugated
secondary antibody (1:1,000; Santa Cruz Biotechnology). Detection of
horseradish peroxidase activity was determined by the enhanced chemi-
luminescence method using luminol and peroxide as the substrate
(Thermo Pierce ECL Western blotting substrate) and subsequently by
exposure to X-ray film.
Dialysismembranechamber (DMC) implantationandmouse infec-
tion. For cultivation of B. burgdorferi in the DMC mammalian host
model, 5ml of spirochetes (103 organisms perml) in BSK-IImediumwere
inoculated into dialysis tubing (Fisherbrand regenerated cellulose) and
implanted into the peritoneal cavities of female Sprague-Dawley rats (two
tubes per rat) (60, 61). For the rat implanted with 5A4NP1 dhhP/
pJJ01IPTG, 10mM IPTGwas added to the drinking water (62). Dialysis
tubing was harvested 14 days after implantation, and the growth of spiro-
chetes were determined by examination of the cultures under the dark-
field microscope.
For mouse infection, 3- or 4-week-old C3H/HeNmice (Harlan, Indi-
anapolis, IN) were subcutaneously inoculated with 1  105 spirochetes.
For mice infected with 5A4NP1 dhhP/pJJ01IPTG, 10 mM IPTG was
added to the drinking water and given via intraperitoneal (IP) injection
(100 l of 10 mM IPTG) every 2 days (62). Ear punch biopsy specimens
were collected 14 days after infection and cultivated in 2 ml of BSK-II
medium (Sigma-Aldrich, St. Louis, MO) containing a mixture of phos-
phomycin (2 mg/ml), rifampin (5 mg/ml), and amphotericin B (250 mg/
ml) (Sigma-Aldrich). All cultures were maintained at 37°C and examined
for the presence of spirochetes by dark-field microscopy beginning 5 days
after inoculation. A single growth-positive culture was used as the crite-
rion to determine positive mouse infection.
RESULTS
B. burgdorferi DhhP (BB0619) is a c-di-AMP phosphodies-
terase. The c-di-AMP-specific phosphodiesterases (PDE) studied
thus far are from Gram-positive bacteria and belong to the GdpP
family (5, 7, 17, 26). GdpP often contains a DHH-DHHA1 do-
main togetherwith several regulatory domains (Fig. 1). TheC-ter-
minal DHH-DHHA1 module is responsible for c-di-AMP cleav-
age (17). A BLAST search revealed that the B. burgdorferi B31
genome encodes a single DHH-DHHA1-containing protein,
BB0619, that lacks other regulatory domains (Fig. 1). We desig-
nated it DhhP (DHH-DHHA1 domain protein).
To investigatewhetherDhhPhas c-di-AMPphosphodiesterase
activity, a C-terminally 6His-tagged recombinant DhhPwas ex-
pressed and purified (Fig. 2A). DhhP was then incubated with
c-di-AMP in reaction buffers containing various metal cations.
The result showed that DhhP hydrolyzed c-di-AMP to 5=-pApA,
with the maximum activity being observed with Mn2 as a cofac-
tor, and the optimal pH of 8.5 (Fig. 2B to D), similar to the obser-
vations made for other c-di-AMP PDEs (5, 17). Mg2 could also
function as an effective metal cofactor, but Zn2 and Ca2 were
inhibitory. Thus, we conclude that B. burgdorferiDhhP has a c-di-
AMP phosphodiesterase activity.
DhhP is essential for cell growth in vitro. To investigate the
function of DhhP in B. burgdorferi, we initially attempted to inac-
tivate dhhP in wild-type B. burgdorferi. However, multiple at-
temptswere unsuccessful.We reasoned that dhhPmaybe essential
for B. burgdorferi, despite the fact that other c-di-AMP PDE genes
have been readily inactivated in other bacteria (8, 16, 17, 21, 22).
To test this hypothesis, we performed a conditional knockout of
dhhP by first transforming the shuttle vector (pJJ01) carrying an
IPTG-inducible dhhP gene into wild-type B. burgdorferi strain
5A4NP1, resulting in strain 5A4NP1/pJJ01 (Fig. 3A). Then the
suicide vector used for inactivation of dhhP was transformed into
5A4NP1/pJJ01 in the presence or absence of IPTG. Ninety-three
positive colonies were obtained with one independent transfor-
mationwhen IPTGwas included in themedium,while no positive
colonies were obtained with 5A4NP1 or 5A4NP1/pJJ01IPTG.
PCR analyses confirmed that these positive clones were condi-
tional dhhP mutants that contain a disrupted endogenous dhhP
gene and an inducible dhhP on the shuttle vector (Fig. 3B). The
endogenous plasmid profiles of the conditional dhhPmutantwere
determined using the method developed by Bunikis et al. (55).
One of the dhhPmutant clones that had plasmid profiles identical
to those of the parental strain, 5A4NP1, was chosen for further
study (Fig. 3C).
FIG 2 Phosphodiesterase activity of B. burgdorferi DhhP in vitro. (A) DhhP-6His protein following affinity purification. (B) Cyclic di-AMP hydrolysis by B.
burgdorferi DhhP monitored by HPLC. The reaction mixture contained 0.5 M DhhP and 50 M c-di-AMP in the buffer (20 mM Tris, 80 mM KCl, 2.5 mM
Mn2 [pH 8.0]) and was incubated at 37°C. Nucleotides were separated and analyzed using reversed-phase HPLC. Shown are nucleotide profiles before (0 min)
and after (1 min incubation) addition of DhhP. (C) Metal cation dependence of c-di-AMP hydrolysis activity of DhhP. (D) pH dependence of c-di-AMP
hydrolysis activity of DhhP.
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To confirm that dhhP is essential for B. burgdorferi growth,
wild-type and the conditional dhhP mutant strains grown in the
presence of IPTG were first harvested and washed to remove
IPTG. The IPTG-free cells were then inoculated into fresh BSK-II
medium supplemented with various concentrations of IPTG. The
result showed that the growth of the conditional dhhPmutant was
IPTG dependent (Fig. 4A). When the initial inoculated culture
concentrationwas high (3 105 spirochetes perml) and the IPTG
concentration was less than 10 M, the dhhPmutant replicated 5
or 6 times and then stopped (reaching about 1 107 spirochetes
per ml) (Fig. 4A). Supplementing the medium with 10 M
IPTG restored the growth of the dhhPmutant to the level of wild-
type spirochetes. To investigate if the dhhP mutant could reach a
density of 107 cells/ml, we inoculated the culture at a lower cell
density (3  104 cells/ml). As shown in Fig. 4B, when IPTG was
absent, the dhhPmutant replicated a few times and stopped, and it
was not able to grow to 107 cells/ml.
We reasoned that the initial small number of replications ob-
served for the conditional dhhP mutant observed in Fig. 4A was
likely due to the presence of DhhP or IPTG in the initial cells used
for inoculation. After cells had replicated several times, DhhP was
depleted or degraded, and the cells then stopped replicating. To
test this possibility, we used stationary-phase cells (Fig. 4A, arrow)
for inoculation into fresh IPTG-free BSK-II medium at a higher
dose (3 105 per ml). As shown in Fig. 4C, the dhhP mutant was
no longer able to replicate even for the first few times. Note that
these cells remained viable under dark-field microscope (data not
shown), and they replicated normally in the medium supple-
mentedwith 1mM IPTG (Fig. 4C). Taking these data together, we
conclude that DhhP is indispensable for the growth of B. burgdor-
feri.
Deletion of dhhP results in an elevated cellular c-di-AMP
level. We first confirmed that the conditional dhhP mutant no
longer expressed dhhP. mRNA was extracted from wild-type cells
or 5A4NP1 dhhP/pJJ01 cells grown with and without IPTG at the
stationary phase (Fig. 4A, arrow). As shown in Fig. 5A, in the
absence of IPTG, the conditional mutant had no detectable level
of dhhP transcript byRT-PCRanalysis.We then subjected the cells
harvested under the same conditions to measurement of the cel-
lular concentrations of c-di-AMP. Given that DhhPwas predicted
to be the only DHH-DHHA-encoding protein in the B. burgdor-
feri genome, inactivation of dhhP was expected to result in an
increased level of c-di-AMP. Indeed, the level of c-di-AMP in-
creased more than 40-fold in the conditional dhhP mutant with-
out IPTG over that in the wild-type B. burgdorferi strain (Fig. 5B).
This result provided in vivo evidence thatDhhP acts as a c-di-AMP
PDE in B. burgdorferi.
DhhP is essential for B. burgdorferi growth in vivo. The data
FIG 3 Construction of the conditional dhhPmutant. (A) Strategy for constructing the dhhPmutant. Arrows indicate the positions of primers (labeled above the
arrows) for PCR analyses. (B) PCR analysis of the wild-type (W) and mutant (M) strains. The specific primer pairs used in PCR are indicated at the top. The
arrows indicate the disrupted endogenous dhhP located in the chromosome (upper arrow) and an inducible copy of dhhP located on the shuttle vector (lower
arrow). (C) Endogenous plasmid profiles of the wild-type (W) and mutant (M) strains obtained by PCR analysis using the method published by Bunikis et al.
(55). cp, circular plasmid; lp, linear plasmid. Letters on each side indicate the bands corresponding to each endogenous plasmid defined previously for B.
burgdorferi strain B31 (32).
FIG4 The dhhPmutant has impaired growth. (A)Wild-type strain and the conditionalmutant 5A4NP1 dhhP/pJJ01were cultured in BSK-IImediumwith 1mM
IPTG, harvested at mid-log phase, and then washed twice with fresh BSK-II medium to remove residual IPTG. The washed cells were then recultured in BSK
mediumwith various concentrations of IPTG.The initial cell densitywas 3 105 cells/ml. Spirocheteswere enumerated under a dark-fieldmicroscope. Each data
point is the average of data from three independent cultures. The arrow indicates the time point taken for the next experiment (C), when cells were at stationary
phase. (B) Same as panel A except that the cultures were inoculated at a lower cell density (3 104 cells/ml). (C) Reinoculation of the stationary-phase cells from
the culture used for panel A into fresh BSK-II medium.
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above showed that the dhhPmutant has an impaired growth phe-
notype under the in vitro cultivation conditions. To determine
whether DhhP is required for B. burgdorferi replication in the
mammalian host environment, the wild type and the 5A4NP1
dhhP/pJJ01 strains with and without IPTG were grown in dialysis
membrane chambers (DMCs) implanted in rat peritoneal cavi-
ties, which were developed by Akins et al. (60). For the IPTG
group, 10 mM IPTG was also provided in rat drinking water (62).
Fourteen days after cultivation, DMCs were harvested and the
cultures were examined under a dark-field microscope. As shown
in Table 3, the wild type and the conditional dhhP mutant spiro-
chetes supplemented with IPTG were readily detectable in DMC
cultures, whereas the dhhPmutantwithout IPTGwas not detected
in DMCs.
We further performed mouse infection experiments for the
conditional dhhP mutants. The wild type and the 5A4NP1 dhhP/
pJJ01 strains were needle inoculated into groups of mice (1 105
spirochetes per mouse). One group of the mice inoculated with
5A4NP1 dhhP/pJJ01 was provided with 100l 10mM IPTG by IP
every 2 days. Fourteen days after inoculation, ear punch biopsy
specimens were collected frommice for cultivation of spirochetal
growth. All mice inoculated with either wild-type B. burgdorferi or
5A4NP1 dhhP/pJJ01 supplied with IPTG were infected. No mice
inoculated with 5A4NP1 dhhP/pJJ01 without IPTGwere infected.
Taken together, these results indicate that DhhP is essential for B.
burgdorferi replication both in vitro and in vivo.
Growth phase-dependent expression of dhhP. Given that
DhhP plays an essential role in B. burgdorferi growth, we investi-
gated whether dhhP expression correlates with the growth rate of
B. burgdorferi. Wild-type B. burgdorferi 5A4NP1 spirochetes
grown in standard BSK-II medium at 37°C were harvested at dif-
ferent growth phases and subjected to qRT-PCR analyses. As
shown in Fig. 6, the dhhP transcript level correlated with the
growth rate. Growth rate-dependent expression of dhhP is consis-
tent with its essential role in B. burgdorferi growth.
The dhhP mutant has elongated cells. Previous reports indi-
cated that alterations in cellular c-di-AMP were associated with
changes in cell morphology. We observed that the conditional
dhhP mutant spirochetes grown in the absence of IPTG had ex-
hibited five times longer cells than the wild type or the 5A4NP1
dhhP/pJJ01 spirochetes grown in the presence of IPTG (Fig. 7),
suggesting that DhhP plays an important role in cell division.
The dhhP mutant does not have increased resistance to
-lactamase antibiotics. Increased intracellular c-di-AMP con-
centration has been shown to affect cell wall/peptidylglycan struc-
ture and lead to increased resistance to -lactam antibiotics in
several Gram-positive bacteria, including B. subtilis, S. aureus, S.
pyogenes, and L. monocytogenes. To examine whether deletion of
dhhP affects B. burgdorferi susceptibility to cell wall-targeting an-
timicrobials, MICs of the conditional dhhP mutant were mea-
sured using the brothmicrodilutionmethod in 96-well tissue cul-
ture plates (56). The wild type and 5A4NP1 dhhP/pJJ01 with or
without IPTG were incubated with a series of dilutions of ampi-
cillin, aztreonam, cefuroxime, cefixime, vancomycin, and oxacil-
lin at 37°C. Note that we inoculated cells at a high dose (106 cells
per ml) so that the growth of the conditional dhhP mutant could
be observed. MICs were calculated 72 h after incubation.
Unlike findings made with Gram-positive bacteria, in which
c-di-AMP pde inactivation resulted in an enhanced antibiotic re-
FIG 5 Inactivation of dhhP results in an increased intracellular c-di-AMP
level. (A) Confirmation of inactivation of dhhP by RT-PCR analyses. Wild-
type spirochetes or the conditional dhhP mutant grown in the absence or
presence (1 mM) of IPTG were taken from cultures at day 4 (Fig. 4A). (B)
Intracellular c-di-AMP concentrations. The IPTG concentration was 1 mM.
Nucleotides were extracted from frozen B. burgdorferi organisms, separated by
HPLC, and quantified by using tandem mass spectrometry as described in
Materials and Methods.
TABLE 3 dhhP is required for Borrelia growth in vivo
Strain Growth in DMC
No. of infected
mice/total
5A4NP1  5/5
5A4NP1 dhhPIPTG  4/4
5A4NP1 dhhPIPTG  0/6
FIG 6 Growth phase-dependent dhhP expression. Wild-type strain 5A4NP1
was grown in standard BSK-II medium at 37°C and harvested at different
stages of growth. M, mid-logarithmic phase; L, late logarithmic phase; S, sta-
tionary phase. Bars represent dhhPmRNA levels, and black dots represent the
culture doubling times. RNAwas extracted and subjected to RT-PCR analysis.
The data are from one representative experiment with three independent cul-
tures. Each data point is the average from three independent cultures.
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sistance, the conditional dhhP mutant of B. burgdorferi did not
exhibit a dramatic increase in resistance (and showed slightly re-
duced resistance [2] to some -lactam antibiotics) (Table 4).
These results suggest that c-di-AMP may function differently in
spirochetes than in Gram-positive bacteria.
The dhhP mutant is defective in producing the major viru-
lence factor OspC. To examine the impact of deletion of dhhP on
the overall protein profile ofB. burgdorferi, whole-cell lysates from
various strains were harvested and subjected to SDS-PAGE anal-
ysis (Fig. 8A). In comparison to the dhhP mutant grown in the
presence of IPTG, the same mutant in the absence of IPTG had
much lower OspC levels. Since ospC expression is controlled by
RpoS, we further examined the levels of RpoS by immunoblotting.
As expected, RpoS was induced in the conditional dhhP mutant
with IPTG, with an increase of cell density (Fig. 8A). However,
RpoS was not detectable in the dhhP mutant in the absence of
IPTG.
It is well established that expression of rpoS is governed by two
transcriptional factors, Rrp2 and BosR (63–65). Regulation of
Rrp2 occurs at the level of phosphorylation. Since a method to
assess the level of Rrp2 phosphorylation within the cell is lacking,
a potential impact of DhhP onRrp2 phosphorylation could not be
examined. Therefore, we focused on regulation of BosR (43, 57,
66). Similar to what was seen with the levels of RpoS, the dhhP
mutant failed to induce BosR production in the absence of IPTG,
indicating that the loss of OspC and RpoS in the dhhPmutant was
due to a defect in BosR production (Fig. 8A). As expected, the
dhhPmutant had no dhhPmRNA and had a significantly reduced
rpoSmRNA level (Fig. 8B and C). However, the bosRmRNA level
was only moderately reduced, with no statistical significance, in
the dhhPmutant (Fig. 8D), suggesting that deletion of dhhP affects
BosR mainly at the posttranscriptional level, a phenomenon that
has been observed under several other conditions (39, 57, 66).
Thus, DhhP appears to be required for BosR accumulation, which
in turn controls production of RpoS and RpoS-dependent viru-
lence factors, including OspC.
DISCUSSION
Virtually all reported studies on the c-di-AMP signaling thus far
have focused on Gram-positive bacteria, with one exception
showing that the Gram-negative pathogen C. trachomatis is also
capable of producing c-di-AMP (27). In this study, we showed
that c-di-AMP signaling is also present in the phylum Spirochae-
tae.We demonstrated, in vitro and in vivo, that the DHH-DHHA1
protein in B. burgdorferi, DhhP, functions as a c-di-AMP PDE.
Unlikewhat has been observed inGram-positive bacteria, DhhP is
required for cell growth of B. burgdorferi.
The requirement of DhhP for growth of B. burgdorferi was
surprising, given that none of the c-di-AMPPDEs has been shown
to be essential for cell growth, but rather, it has been demonstrated
that diadenylate cyclase is indispensable for cell survival in all
Gram-positive bacteria examined. Furthermore, the reported
PDE-defective mutants (containing increased intracellular c-di-
AMP levels) have elevated resistance to peptidoglycan-targeted
antibiotics in S. aureus (21),B. subtilis (15), S. pyogenes (26), andL.
monocytogenes (8).However, deletion of dhhPofB. burgdorferidid
not result in an increased resistance to cell wall-targeting antibi-
otics (Table 4). Since increased antibiotic resistance in c-di-AMP
PDE mutants has been linked to an increased amount of cross-
linked peptidoglycan in S. aureus (21), we also examined the dhhP
mutant of B. burgdorferi using cryo-electron microscopy in col-
laboration with Jun Liu at the University of Texas at Houston.We
did not observe any significant change in the thickness of the pep-
tidoglycan layer (data not shown). Another phenotype of the dhhP
mutant that is different from the phenotypes of other PDE mu-
tants in Gram-positive bacteria concerned differences in cell
shape. The dhhP mutant of B. burgdorferi had an increased cell
length, whereas inactivation of gdpP resulted in a reduced cell size
of S. aureus (21). In B. subtilis, curled nonseparated cell filaments
were observed upon cellular accumulation of c-di-AMP (67). All
these findings suggest that c-di-AMP may function differently in
modulating cell wall homeostasis of B. burgdorferi. As spirochetes
TABLE 4 MIC of B. burgdorferi strains for various antibiotics
Strain
MIC (g/ml) of:
Ampicillin Aztreonam Cefuroxime Cefixime Vancomycin Oxacillin
5A4NP1 2.5 25 0.156 0.625 0.625 1.25
5A4NP1 dhhP/pJJ01IPTG 2.5 25 0.156 0.625 0.625 1.25
5A4NP1 dhhP/pJJ01IPTG 1.25 25 0.156 0.625 0.312 0.625
FIG 7 The dhhP mutant is defective in cell division. (A) Morphology of
5A4NP1 dhhP/pJJ01 grown with IPTG or 5A4NP1 dhhP/pJJ01 grown without
IPTG examined under a dark-field microscope. Images were taken at a mag-
nification of 500. (B) Quantitation of cell length. A total of 100 randomly
selected cells from each strain were measured.
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have a cell wall structure similar to that of Gram-negative bacteria
(with dual membranes), it will be interesting to investigate the
roles of c-di-AMP phosphodiesterases in proteobacteria that ap-
pear to possess c-di-AMP signaling pathways (5).
Most of the c-di-AMP PDEs reported thus far have been
grouped into the GdpP family, including B. subtilis YybT (17), S.
aureusGdpP, S. pyogenesGdpP (26), and S. pneumoniae Pde1 (7).
BesidesDHH-DHHA1domains responsible for c-di-AMPhydro-
lysis, proteins in the GdpP family contain an additional degener-
ate GGDEF domain and PAS domain (5). An intact GGDEF do-
main is responsible for diguanylate cyclase activity involved in
synthesis of c-di-GMP (34, 68, 69). The GGDEF domain within
GdpP, however, has no such activity but is capable of hydrolyzing
ATP (17) and may regulate the activity of the DHH-DHHA1 do-
mains (21). The PAS domain in GdpP has been shown to bind to
heme and plays a regulatory role in c-di-AMP PDE’s activity (70).
These proteins also have transmembrane domains and are associ-
ated with the cell membrane (5). In this regard, B. burgdorferi
DhhPhas a singleDHH-DHHA1domainmodule and lacks trans-
membrane and regulatory domains. This domain structure sug-
gests that DhhP is a cytoplasmic protein and its activity may be
regulated at the level of gene expression, not at the level of its
enzymatic activity. In this study, we showed that dhhP expression
is growth phase dependent, being highest during the exponential
phase (Fig. 6).
Given that the dhhP mutant has an impaired growth pheno-
type under the in vitro cultivation conditions, it was not surprising
that the samemutantwas not able to replicate in the dialysismem-
brane implanted in the rat peritoneal cavity (theDMCconditions)
or when directly inoculated into mice. These results suggest that
the requirement for DhhP does not depend on the environmental
niches where B. burgdorferi resides, and elevated levels of c-di-
AMP likely inhibit one ormore cellular processes that are essential
for B. burgdorferi growth. One of the cellular processes affected by
c-di-AMP may be cell division, as the conditional c-di-AMP mu-
tant showed increased cell length (Fig. 7). The dhhP mutant was
also unable to produce RpoS and RpoS-dependent virulence fac-
tors, such as OspC. This defect could be simply due to its growth
defect, as induction of RpoS and OspC is growth rate dependent
(71).
This study focused on c-di-AMP PDE of B. burgdorferi. Inacti-
vation of dhhP resulted in accumulation of cellular c-di-AMP,
indicating that B. burgdorferi is capable of producing the second
messenger c-di-AMP. The enzyme diadenylate cyclase (DAC) for
c-di-AMP synthesis contains a conservedDisA_Ndomain (21). In
this regard, we have found that the hypothetical protein BB0008 in
the B. burgdorferi genome encodes a putative DisA_N domain (E
value 	 5.45e-34), which makes BB0008 a strong candidate as a
DAC of B. burgdorferi. Currently, no information is available
about BB0008; its expression is not regulated by temperature,
DMC conditions, or the two-component system Hk1-Rrp1 or
Hk2-Rrp2 based on the published microarray data (37, 38, 72–
79). We are currently in the process of investigating the role of
BB0008 in the c-di-AMP signaling of B. burgdorferi.
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